(Q48523669)

12 February 2018

title

Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer. (English)

1 reference

12 February 2018

nucleic acid sequence analysis

main subject

1 reference

5

1 reference

12 February 2018

Charlotte Fribbens

object named as

C Fribbens

1

0 references

author name string

I Garcia Murillas

2

1 reference

12 February 2018

M Beaney

3

1 reference

12 February 2018

S Hrebien

4

1 reference

12 February 2018

L Kilburn

6

1 reference

12 February 2018

K Howarth

7

1 reference

12 February 2018

M Epstein

8

1 reference

12 February 2018

E Green

9

1 reference

12 February 2018

N Rosenfeld

10

1 reference

12 February 2018

A Ring

11

1 reference

12 February 2018

S Johnston

12

1 reference

12 February 2018

N Turner

13

1 reference

12 February 2018

publication date

4 October 2017

1 reference

12 February 2018

published in

Annals of Oncology

1 reference

12 February 2018

volume

29

1 reference

12 February 2018

issue

1

1 reference

12 February 2018

page(s)

145-153

1 reference

12 February 2018

Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX483

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX483

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX483

ESR1 ligand-binding domain mutations in hormone-resistant breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX483

Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX483

Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX483

Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX483

Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, mult

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX483

Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX483

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX483

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX483

Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX483

Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDX483

Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor

21 January 2018

1 reference

12 December 2020

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

1 reference

12 December 2020

Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNA.

1 reference

12 December 2020

Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.

1 reference

12 December 2020

Identifiers

DOI

10.1093/ANNONC/MDX483

1 reference

12 February 2018

PMC publication ID

6264798

0 references

1 reference

12 February 2018